SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE) will present at the Inaugural Gilmartin Group Emerging Growth Company Showcase on August 31, 2022, at 9:30 a.m. PT / 12:30 p.m. ET. The presentation will be available via a live webcast, and an archived version can be accessed later on the SeaSpine investor relations website. SeaSpine specializes in surgical solutions for spinal disorders, providing market-leading technology and a diverse range of spinal implants and orthobiologics to enhance surgical accuracy and efficiency.

CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 9:30 a.m. Pacific time / 12:30 p.m. Eastern time.

Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the Investors section of the SeaSpine website at https://investor.seaspine.com/

Parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.

About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine’s complete procedural solutions feature its market-leading FLASH™ Navigation, a system designed to improve accuracy of screw placement and provide a cost-effective, rapid, radiation-free solution to surgical navigation, and a comprehensive portfolio of spinal implants and orthobiologics to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures on the lumbar, thoracic and cervical spine. With product development expertise in advanced optics, software, orthobiologic sciences and spinal implants, SeaSpine can offer its surgeon customers a complete solution to meet their patients’ evolving clinical needs. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

Investor Relations Contact
Leigh Salvo
ir@seaspine.com

Source: SeaSpine Holdings Corporation

FAQ

When will SeaSpine present at the Gilmartin Group Emerging Growth Company Showcase?

SeaSpine will present on August 31, 2022, at 9:30 a.m. Pacific time / 12:30 p.m. Eastern time.

How can I access SeaSpine's presentation during the showcase?

You can access the live webcast of SeaSpine's presentation through a link provided in their press release.

What is the focus of SeaSpine Holdings Corporation?

SeaSpine focuses on surgical solutions for the treatment of spinal disorders, offering advanced technology and spinal implants.

Is there an archived version of SeaSpine's presentation available?

Yes, an archived version will be available on SeaSpine's investor relations website after the live presentation.

What is the significance of the Gilmartin Group Emerging Growth Company Showcase for SeaSpine?

The showcase provides an opportunity for SeaSpine to present its advancements and growth in the medical technology sector.